INR:2770. women's cricket t20 141 genes may help explain genetic risk for asthma, hay fever and eczema Generic drugs don’t make money, the innovation track ...

INR:3072. rummy fast win Sanofi/Regeneron's new childhood asthma drug Dupixent enters review in the U.S. EU approves AZ/Daiichi Sankyo Enhertu for advanced breast ...

evolution gambling AstraZeneca/Amgen tezepelumab Phase III asthma trial meets primary endpoint Who is leading the multi-billion dollar atopic dermatitis drug market? Will the first product of ...

10cric withdrawal process Sanofi/Regeneron Dupixent for severe asthma rejected by NICE! Osaikondalusconid is accepted. Is Novartis' $1 billion drug facing a "crisis"? Vitrakvi, an anticancer drug that ...